5-HT5A receptor (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "5-HT5A receptor" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

9nih.gov

4^th place

3^rd place

6doi.org

2^nd place

2web.archive.org

1^st place

1aspetjournals.org

6,663^rd place

1,410^th place

1if-pan.krakow.pl

low place

aspetjournals.org

molpharm.aspetjournals.org

Matthes H, Boschert U, Amlaiky N, Grailhe R, Plassat JL, Muscatelli F, Mattei MG, Hen R (March 1993). „Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization”. Mol. Pharmacol. 43 (3): 313–9. PMID 8450829. Arhivirano iz originala na datum 2008-12-02. Pristupljeno 2014-05-02.

doi.org

dx.doi.org

Rees S, den Daas I, Foord S, Goodson S, Bull D, Kilpatrick G, Lee M (December 1994). „Cloning and characterisation of the human 5-HT5A serotonin receptor”. FEBS Lett. 355 (3): 242–6. DOI:10.1016/0014-5793(94)01209-1. PMID 7988681.
Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE (November 1998). „The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells”. Eur. J. Pharmacol. 361 (2-3): 299–309. DOI:10.1016/S0014-2999(98)00744-4. PMID 9865521.
Nelson DL (February 2004). „5-HT5 receptors”. Curr Drug Targets CNS Neurol Disord 3 (1): 53–8. DOI:10.2174/1568007043482606. PMID 14965244.
Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L (January 2008). „Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration”. Bioorg. Med. Chem. Lett. 18 (1): 262–6. DOI:10.1016/j.bmcl.2007.10.078. PMID 18023344.
Dietz BM, Mahady GB, Pauli GF, Farnsworth NR (August 2005). „Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro”. Brain Res. Mol. Brain Res. 138 (2): 191–7. DOI:10.1016/j.molbrainres.2005.04.009. PMID 15921820.
Wu J, Li Q, Bezprozvanny I (2008). „Evaluation of Dimebon in cellular model of Huntington's disease”. Mol Neurodegener 3 (1): 15. DOI:10.1186/1750-1326-3-15. PMC 2577671. PMID 18939977.

if-pan.krakow.pl

Wesołowska A (2002). „In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors”. Pol J Pharmacol 54 (4): 327–41. PMID 12523486. Arhivirano iz originala na datum 2023-09-19. Pristupljeno 2014-05-02.

nih.gov

ncbi.nlm.nih.gov

„Entrez Gene: HTR5A 5-hydroxytryptamine (serotonin) receptor 5A”.
Rees S, den Daas I, Foord S, Goodson S, Bull D, Kilpatrick G, Lee M (December 1994). „Cloning and characterisation of the human 5-HT5A serotonin receptor”. FEBS Lett. 355 (3): 242–6. DOI:10.1016/0014-5793(94)01209-1. PMID 7988681.
Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE (November 1998). „The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells”. Eur. J. Pharmacol. 361 (2-3): 299–309. DOI:10.1016/S0014-2999(98)00744-4. PMID 9865521.
Matthes H, Boschert U, Amlaiky N, Grailhe R, Plassat JL, Muscatelli F, Mattei MG, Hen R (March 1993). „Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization”. Mol. Pharmacol. 43 (3): 313–9. PMID 8450829. Arhivirano iz originala na datum 2008-12-02. Pristupljeno 2014-05-02.
Nelson DL (February 2004). „5-HT5 receptors”. Curr Drug Targets CNS Neurol Disord 3 (1): 53–8. DOI:10.2174/1568007043482606. PMID 14965244.
Wesołowska A (2002). „In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors”. Pol J Pharmacol 54 (4): 327–41. PMID 12523486. Arhivirano iz originala na datum 2023-09-19. Pristupljeno 2014-05-02.
Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L (January 2008). „Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration”. Bioorg. Med. Chem. Lett. 18 (1): 262–6. DOI:10.1016/j.bmcl.2007.10.078. PMID 18023344.
Dietz BM, Mahady GB, Pauli GF, Farnsworth NR (August 2005). „Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro”. Brain Res. Mol. Brain Res. 138 (2): 191–7. DOI:10.1016/j.molbrainres.2005.04.009. PMID 15921820.
Wu J, Li Q, Bezprozvanny I (2008). „Evaluation of Dimebon in cellular model of Huntington's disease”. Mol Neurodegener 3 (1): 15. DOI:10.1186/1750-1326-3-15. PMC 2577671. PMID 18939977.

web.archive.org

Matthes H, Boschert U, Amlaiky N, Grailhe R, Plassat JL, Muscatelli F, Mattei MG, Hen R (March 1993). „Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization”. Mol. Pharmacol. 43 (3): 313–9. PMID 8450829. Arhivirano iz originala na datum 2008-12-02. Pristupljeno 2014-05-02.
Wesołowska A (2002). „In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors”. Pol J Pharmacol 54 (4): 327–41. PMID 12523486. Arhivirano iz originala na datum 2023-09-19. Pristupljeno 2014-05-02.